后路保留肌肉选择性椎板切除术与椎板切除融合术治疗脊髓型颈椎病的比较:一项随机对照试验的研究方案
本研究为多中心随机对照平行组非劣效性试验,计划纳入300例成人脊髓型颈椎病(CSM)患者,按1:1分配至后路保留肌肉选择性椎板切除术组或后路椎板切除加器械融合组。主要终点为5年随访时因任何原因再手术,样本量与把握度基于瑞典脊柱登记(Swespine)数据估算(椎板切除术后再手术率3.5%,椎板切除加融合术后7.4%)。
要点
- 主要终点为5年随访时因任何原因再手术,样本量按椎板切除术3.5%、椎板切除加融合术7.4%的再手术率估算。
- 纳入标准为C3-C7亚轴脊柱1-4个节段的CSM,共300例成人按1:1随机分配。
- 术后3、12、24、60个月进行临床与影像学随访,数据按改良意向治疗(mITT)人群分析。
核心结论
- 这是首个比较CSM两种最常见后路手术(后路保留肌肉选择性椎板切除术与后路椎板切除加器械融合术)的随机对照试验。
- MyRanC研究结果将为CSM提供手术治疗推荐,可能改善CSM的手术治疗与临床实践。
研究设计与样本
- 多中心随机对照平行组非劣效性试验,共300例成人患者按1:1分配。
- 主要纳入标准为C3-C7亚轴脊柱1-4个节段的CSM。
- 采用REDcap软件进行数据安全管理,按改良意向治疗(mITT)人群分析,mITT定义为随机分组后2年和5年时仍存活且未移居或退出研究的患者。
- 随访时间为术后3、12、24、60个月。
主要发现
- 主要终点为5年随访时因任何原因再手术。
- 样本量与把握度计算基于瑞典脊柱登记(Swespine)CSM患者数据,估计椎板切除术后再手术率为3.5%,椎板切除加融合术后为7.4%。
- 次要结局包括患者自评日本骨科协会(P-mJOA)评分、颈功能障碍指数(NDI)、欧洲五维健康量表(EQ-5D)、颈部和手臂疼痛数字评定量表(NRS)、医院焦虑抑郁量表(HADS)、以颈椎矢状垂直轴(cSVA)测量的后凸发展及死亡。
关键数值与推荐
- 主要终点:5年随访时因任何原因再手术。
- 样本量估算依据:椎板切除术后再手术率3.5%,椎板切除加融合术后再手术率7.4%(数据来自Swespine)。
- 纳入标准:C3-C7亚轴脊柱1-4个节段的CSM。
- 随访时点:术后3、12、24、60个月。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cervical spondylotic myelopathy (CSM) is the predominant cause of spinal cord dysfunction in the elderly. The patients are often frail and susceptible to complications. Posterior surgical techniques involving non-fusion are complicated by postlaminectomy kyphosis and instrumented fusion techniques by distal junction kyphosis, pseudarthrosis, or implant failure. The optimal surgical approach is still a matter of controversy. Since anterior and posterior fusion techniques have been compared without presenting any superiority, the objective of this study is to compare stand-alone laminectomy with laminectomy and fusion to determine which treatment has the lowest frequency of reoperations. METHODS: This is a multicenter randomized, controlled, parallel-group non-inferiority trial. A total of 300 adult patients are allocated in a ratio of 1:1. The primary endpoint is reoperation for any reason at 5 years of follow-up. Sample size and power calculation were performed by estimating the reoperation rate after laminectomy to 3.5% and after laminectomy with fusion to 7.4% based on the data from the Swedish spine registry (Swespine) on patients with CSM. Secondary outcomes are the patient-derived Japanese Orthopaedic Association (P-mJOA) score, Neck Disability Index (NDI), European Quality of Life Five Dimensions (EQ-5D), Numeric Rating Scale (NRS) for neck and arm pain, Hospital Anxiety and Depression Scale (HADS), development of kyphosis measured as the cervical sagittal vertical axis (cSVA), and death. Clinical and radiological follow-up is performed at 3, 12, 24, and 60 months after surgery. The main inclusion criterium is 1-4 levels of CSM in the subaxial spine, C3-C7. The REDcap software will be used for safe data management. Data will be analyzed according to the modified intention to treat (mITT) population, defined as randomized patients who are still alive without having emigrated or left the study after 2 and 5 years. DISCUSSION: This will be the first randomized controlled trial comparing two of the most common surgical treatments for CSM: the posterior muscle-preserving selective laminectomy and posterior laminectomy with instrumented fusion. The results of the myelopathy randomized controlled (MyRanC) study will provide surgical treatment recommendations for CSM. This may result in improvements in surgical treatment and clinical practice regarding CSM. TRIAL REGISTRATION: ClinicalTrials.gov NCT04936074 . Registered on 23 June 2021.
引用
- MacDowall A, Löfgren H, Edström E, et al. Comparison of posterior muscle-preserving selective laminectomy and laminectomy with fusion for treating cervical spondylotic myelopathy: study protocol for a randomized controlled trial. Trials. 2023. PMID: 36765352. doi:10.1186/s13063-023-07123-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。